We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

Western Hair-Loss Drugs Becoming Popular In China, Study Shows

June 13, 2013: 12:00 AM EST
Hair-loss drugs from Western companies, including Merck's Propecia and Johnson & Johnson's Rogaine, are becoming popular in China, where luxuriant hair is a sign of health and virility. Sales of hair-loss treatments, most of which come with Rogaine's active ingredient, minoxidil, increased 90 percent to 100.7 million yuan in the five-year period ending in 2012, according to Euromonitor International. Results of a survey of 1,280 balding men in several cities by the China Association of Health Promotion and Education revealed 47 percent of respondents said they had used hair-growth shampoos, visited hair-loss centers, or even resorted to swallowing snake gallbladders. The top hair-loss treatment in China in terms of sales in 2012 was Da Fei Xin, a minoxidil solution from Shanxi Zhendong Pharmaceutical, which accounted for 23 percent of the market.
Daryl Loo and Lisa Pham, "Hair-Loss Drugs' Big Growth in China", Bloomberg, June 13, 2013, © Bloomberg L.P.
China Business
Focus Areas
Personal Care
Market News
Market News
Products & Brands
Developed by Yuri Ingultsov Software Lab.